# Once-daily Regimen With Envarsus® to Optimize Immunosuppression Management and Outcomes in Kidney Transplant Recipients

> **NCT02954198** · NA · COMPLETED · sponsor: **Medical University of South Carolina** · enrollment: 40 (actual)

## Conditions studied

- Immunosuppression

## Interventions

- **DRUG:** Tacrolimus
- **DRUG:** Prednisone
- **DRUG:** Mycophenolate mofetil
- **DRUG:** Everolimus

## Key facts

- **NCT ID:** NCT02954198
- **Lead sponsor:** Medical University of South Carolina
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-01
- **Primary completion:** 2018-12-27
- **Final completion:** 2018-12-27
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2019-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02954198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02954198, "Once-daily Regimen With Envarsus® to Optimize Immunosuppression Management and Outcomes in Kidney Transplant Recipients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02954198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*